GC Corp.
005250.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$438.49B
Close$
Share Statistics
| Market cap | $438.49 Billion |
|---|---|
| Enterprise Value | $2.10 Trillion |
| Dividend Yield | $300.00 (3.08%) |
| Earnings per Share | $-1531.06 |
| Beta | 0.56 |
| Outstanding Shares | 45,402,000 |
Return
| Return on Equity | -14.07% |
|---|---|
| Return on Assets | -2.92% |
| Return on Invested Capital | 2.02% |
Valuation & Multiples
| P/E Ratio | -3.62 |
|---|---|
| PEG | 3.8 |
| Price to Sales | 0.17 |
| Price to Book Ratio | 0.25 |
| Enterprise Value to Revenue | 0.84 |
| Enterprise Value to EBIT | 41.82 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | 2.01 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GC Corp.
163 employees
CEO: Yong-Jun Huh GC Corp., formerly known as Green Cross Holdings Corporation, is a South Korean biotechnology company. It provides a range of products including prescription drugs, vaccines, and blood plasma derivatives, and also offers pharmaceutical logistics and cell therapy services.